
HomeSpecialty IngredientNADHelp+® Apigenin by Bonerge Lifescience
NADHelp+® Apigenin by Bonerge Lifescience
NADHelp+® Apigenin by Bonerge Lifescience
NADHelp+® Apigenin by Bonerge Lifescience is a high-purity NAD+ promoter standardized to not less than 98% by HPLC. Derived from naringin in grapefruit extract, this off-white to yellowish powder follows compendial manufacturing under strict quality controls. Non-GMO, gluten-free, allergen-free, and BSE/TSE-free, NADHelp+® supports cellular, cardiovascular, and skin health applications. Produced using eco-efficient extraction, it ensures batch consistency and excellent stability, aligning with Bonerge’s pharmaceutical-grade analytical standards.
0
0 out of 5 stars (based on 0 endorsements)
General
Item #:
Company:
Technology:
Name:
NADHelp+® Apigenin
Ingredient/s:
Apigenin
Categories:
Anti- Aging, Brain Health, Cellular Health, Heart Health, Metabolic Health
Dosage (min):
Dosage (max):
MOQ:
Price kg:
Botanical Names:
Active/s:
Apigenin
Assay:
Standardized to not less than 98% by HPLC
Country of Origin:
Suppliers:
Bonerge Lifescience
Contact Information
Email:
Documents (Coming Soon)
Upgrade your account to access documents
COMING SOON
Cheat Sheet Card
100% Natural
Vegan
Gluten Free
Non-GMO
GRAS
Water Soluble
Wild-Harvested
Allergen Free
Key Certifications
Halal Certified
Kosher Certified
Vegan Certified
USDA Organic
NON-GMO Project Verified
Gluten-Free Certified
Send an Inquiry
Ingredient Highlights
NADHelp+® Apigenin features clinically supported actives shown to help:
- Supports CD38 inhibition and NAD+ preservation.*
- Promotes antioxidant and neuroprotective effects.*
- Improves cellular energy and longevity pathways.*
- Supports calm focus and healthy cognition.*
- Enhances metabolic regulation and stress response.*
- Promotes NAD+ synergy with other ingredients.*
- Supports systemic resilience and energy vitality.*
Featured Content
Product type
Endorsement
0
0 out of 5 stars (based on 0 endorsements)
Excellent
Very good
Average
Poor
Terrible
There are no reviews yet. Be the first one to write one.











